Skip to main content

Market Overview

US Stock Futures Surge Ahead Of Economic Data

US Stock Futures Surge Ahead Of Economic Data

Pre-open movers

US stock futures traded higher in early pre-market trade, ahead of economic data. Data on durable goods orders for April will be released at 8:30 a.m. ET, while the FHFA house price index and the S&P/Case-Shiller home price index for March will be released at 9:00 a.m. ET. The Markit PMI services (flash) for May will be released at 9:45 a.m. ET, while the Conference Board's consumer confidence index and the Richmond Fed manufacturing index for May will be released at 10:00 a.m. ET. The Dallas Fed general business activity index for May will be released at 10:30 a.m. ET. Futures for the Dow Jones Industrial Average surged 72 points to 16,658.00, while the Standard & Poor's 500 index futures rose 8.80 points to 1,905.70. Futures for the Nasdaq 100 index gained 19.50 points to 3,694.50.

A Peek Into Global Markets

European markets were mostly higher today, with the Spanish Ibex Index rising 0.24%, STOXX Europe 600 Index gaining 0.17%. German DAX 30 index surged 0.35%, French CAC 40 Index fell 0.01% and London's FTSE 100 Index gained 0.52%. French consumer confidence remained unchanged at 85 in May.

In Asian markets, Japan's Nikkei Stock Average jumped 0.23%, Hong Kong's Hang Seng Index fell 0.08%, China's Shanghai Composite Index fell 0.34% and India's BSE Sensex tumbled 0.68%. India's current account deficit narrowed to $1.2 billion in the three months ended March, from $18.1 billion deficit in the year-ago period.

Broker Recommendation

Analysts at Goldman Sachs downgraded Staples (NASDAQ: SPLS) from “neutral” to “sell.” The target price for Staples has been lowered from $11.50 to $11.

Staples' shares fell 3% to $11.30 in pre-market trading.

Breaking news

  • Willis Group Holdings plc (NYSE: WSH) announced today that it will acquire a controlling stake of approximately 75% in Max Matthiessen, a leading employee benefits adviser in Sweden, for $205 million. To read the full news, click here.
  • BioCryst Pharmaceuticals (NASDAQ: BCRX) today announced preliminary results from its OPuS-1 (Oral ProphylaxiS-1) proof of concept Phase 2a clinical trial of orally-administered BCX4161 in patients with hereditary angioedema (HAE). To read the full news, click here.
  • Bank of Nova Scotia (NYSE: BNS) posted a 14% rise in its FQ2 profit. Scotiabank's quarterly earnings jumped to 1.8 billion Canadian dollars ($1.66 billion), or C$1.39 per share, versus C$1.58 billion, or C$1.22 per share, in the year-ago period. To read the full news, click here.
  • AutoZone (NYSE: AZO) reported a rise in its fiscal third-quarter profit. AutoZone's quarterly earnings surged to $285.2 million, or $8.46 per share, versus $265.6 million, or $7.27 per share, in the year-ago quarter. To read the full news, click here.

Related Articles (SPLS + WSH)

View Comments and Join the Discussion!

Posted-In: Goldman Sachs US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at